Breast cancer stem cells: Obstacles to therapy, Cancer Letters, vol.338, issue.1, pp.57-62, 2013. ,
DOI : 10.1016/j.canlet.2012.04.023
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells, Cell, vol.133, issue.4, pp.704-715, 2008. ,
DOI : 10.1016/j.cell.2008.03.027
Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis, Journal of Clinical Investigation, vol.122, issue.6, pp.2066-2078, 2012. ,
DOI : 10.1172/JCI59735DS1
URL : http://www.jci.org/articles/view/59735/files/pdf
FOXC2 Expression Links Epithelial-Mesenchymal Transition and Stem Cell Properties in Breast Cancer, Cancer Research, vol.73, issue.6, pp.1981-1992, 2013. ,
DOI : 10.1158/0008-5472.CAN-12-2962
URL : http://cancerres.aacrjournals.org/content/canres/73/6/1981.full.pdf
Engineering lymphocyte subsets: tools, trials and tribulations, Nature Reviews Immunology, vol.112, issue.10, pp.704-716, 2009. ,
DOI : 10.4049/jimmunol.172.1.104
URL : http://europepmc.org/articles/pmc3412112?pdf=render
Adoptive immunotherapy for cancer: harnessing the T cell response, Nature Reviews Immunology, vol.3, issue.4, pp.269-281, 2012. ,
DOI : 10.1126/scitranslmed.3002949
Adoptive cell transfer as personalized immunotherapy for human cancer, Science, vol.385, issue.224, pp.62-68, 2015. ,
DOI : 10.1016/S0140-6736(14)61403-3
Human ???? T-cell responses in infection and immunotherapy: Common mechanisms, common mediators?, European Journal of Immunology, vol.22, issue.7, pp.1668-1676, 2012. ,
DOI : 10.1016/j.smim.2010.04.004
URL : http://onlinelibrary.wiley.com/doi/10.1002/eji.201242492/pdf
What lessons can be learned from ???? T cell-based cancer immunotherapy trials?, Cellular & Molecular Immunology, vol.8, issue.1, pp.35-41, 2013. ,
DOI : 10.1038/nrclinonc.2010.223
???? T cells for cancer immunotherapy, OncoImmunology, vol.154, issue.1, p.27572, 2014. ,
DOI : 10.1158/0008-5472.CAN-10-3862
???? T cells in cancer, Nature Reviews Immunology, vol.45, issue.11, pp.683-691, 2015. ,
DOI : 10.1016/0092-8674(86)90388-0
Efficient Killing of Human Colon Cancer Stem Cells by ???? T Lymphocytes, The Journal of Immunology, vol.182, issue.11, pp.7287-7296, 2009. ,
DOI : 10.4049/jimmunol.0804288
URL : http://www.jimmunol.org/content/jimmunol/182/11/7287.full.pdf
Human ovarian cancer stem-like cells can be efficiently killed by ???? T lymphocytes, Cancer Immunology, Immunotherapy, vol.31, issue.2, pp.979-989, 2012. ,
DOI : 10.1002/eji.201041282
Zoledronate Sensitizes Neuroblastoma-derived Tumor-initiating Cells to Cytolysis Mediated by Human ???? T Cells, Journal of Immunotherapy, vol.35, issue.8, pp.598-606, 2012. ,
DOI : 10.1097/CJI.0b013e31826a745a
Reduced Expression of the Mevalonate Pathway Enzyme Farnesyl Pyrophosphate Synthase Unveils Recognition of Tumor Cells by V??9V??2 T Cells, The Journal of Immunology, vol.182, issue.12, pp.8118-8124, 2009. ,
DOI : 10.4049/jimmunol.0900101
Phase I Trial of a Novel Anti-GD2 Monoclonal Antibody, Hu14.18K322A, Designed to Decrease Toxicity in Children With Refractory or Recurrent Neuroblastoma, Journal of Clinical Oncology, vol.32, issue.14, pp.1445-1452, 2014. ,
DOI : 10.1200/JCO.2013.50.4423
Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells, Genes & Development, vol.15, issue.1, pp.50-65, 2001. ,
DOI : 10.1101/gad.828901
URL : http://genesdev.cshlp.org/content/15/1/50.full.pdf
Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells, Proceedings of the National Academy of Sciences, vol.203, issue.3, pp.4968-4973, 2013. ,
DOI : 10.1111/j.1432-1033.1992.tb16586.x
Antitumor Immunity and Cancer Stem Cells, Annals of the New York Academy of Sciences, vol.278, issue.1, pp.154-169, 2009. ,
DOI : 10.4049/jimmunol.174.5.2591
???? T Cells Provide an Early Source of Interferon ?? in Tumor Immunity, The Journal of Experimental Medicine, vol.65, issue.3, pp.433-442, 2003. ,
DOI : 10.1084/jem.183.4.1681
URL : http://jem.rupress.org/content/jem/198/3/433.full.pdf
Monocytes and ???? T cells control the acute-phase response to intravenous zoledronate: Insights from a phase IV safety trial, Journal of Bone and Mineral Research, vol.19, issue.11, pp.464-471, 2013. ,
DOI : 10.1007/s00262-011-1049-8
URL : http://onlinelibrary.wiley.com/doi/10.1002/jbmr.1797/pdf
Activation of Human ???? T Cells by Cytosolic Interactions of BTN3A1 with Soluble Phosphoantigens and the Cytoskeletal Adaptor Periplakin, The Journal of Immunology, vol.194, issue.5, pp.2390-2398, 2015. ,
DOI : 10.4049/jimmunol.1401064
Production of TNF-?? by Human V??9V??2 T Cells Via Engagement of Fc??RIIIA, the Low Affinity Type 3 Receptor for the Fc Portion of IgG, Expressed upon TCR Activation by Nonpeptidic Antigen, The Journal of Immunology, vol.166, issue.12, pp.7190-7199, 2001. ,
DOI : 10.4049/jimmunol.166.12.7190
Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies, Blood, vol.113, issue.20, pp.4875-4884, 2009. ,
DOI : 10.1182/blood-2008-08-172296
URL : http://www.bloodjournal.org/content/bloodjournal/113/20/4875.full.pdf
Stimulated ???? T Cells Increase the In Vivo Efficacy of Trastuzumab in HER-2+ Breast Cancer, The Journal of Immunology, vol.187, issue.2, pp.1031-1038, 2011. ,
DOI : 10.4049/jimmunol.1100681
Natural Innate and Adaptive Immunity to Cancer, Annual Review of Immunology, vol.29, issue.1, pp.235-271, 2011. ,
DOI : 10.1146/annurev-immunol-031210-101324
Adoptive T-Cell Therapy for Cancer, Adv Immunol, vol.130, pp.279-294, 2016. ,
DOI : 10.1016/bs.ai.2015.12.006
Adoptive cellular therapy: A race to the finish line, Science Translational Medicine, vol.7, issue.280, pp.280-287, 2015. ,
DOI : 10.1158/0008-5472.CAN-11-2837
Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells, Cancer Research, vol.70, issue.2, pp.697-708, 2010. ,
DOI : 10.1158/0008-5472.CAN-09-1592
URL : http://cancerres.aacrjournals.org/content/canres/70/2/697.full.pdf
Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients, Clinical Cancer Research, vol.16, issue.3, pp.800-813, 2010. ,
DOI : 10.1158/1078-0432.CCR-09-2730
Induction of metastatic cancer stem cells from the NK/LAK-resistant floating, but not adherent, subset of the UP-LN1 carcinoma cell line by IFN-??, Laboratory Investigation, vol.26, issue.10, pp.1502-1513, 2011. ,
DOI : 10.1007/s10555-010-9233-4
Human NK Cells Selective Targeting of Colon Cancer-Initiating Cells: A Role for Natural Cytotoxicity Receptors and MHC Class I Molecules, The Journal of Immunology, vol.190, issue.5, pp.2381-2390, 2013. ,
DOI : 10.4049/jimmunol.1201542
URL : http://www.jimmunol.org/content/jimmunol/190/5/2381.full.pdf
Recognition and killing of brain tumor stem-like initiating cells by CD8 + cytolytic T cells, Cancer Res, vol.69, pp.8886-8893, 2009. ,
Susceptibility to cytotoxic T cell lysis of cancer stem cells derived from cervical and head and neck tumor cell lines, Journal of Cancer Research and Clinical Oncology, vol.2, issue.4, pp.159-170, 2013. ,
DOI : 10.1097/00008571-199208000-00001
Targeting ALDHbright Human Carcinoma-Initiating Cells with ALDH1A1-Specific CD8+ T Cells, Clinical Cancer Research, vol.17, issue.19, pp.6174-6184, 2011. ,
DOI : 10.1158/1078-0432.CCR-11-1111
URL : http://clincancerres.aacrjournals.org/content/clincanres/17/19/6174.full.pdf
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel, Annals of Oncology, vol.31, issue.(Suppl 1), pp.379-390, 2016. ,
DOI : 10.1158/0008-5472.CAN-10-3862
URL : https://academic.oup.com/annonc/article-pdf/27/3/379/16700079/mdv617.pdf
Adjuvant zoledronic acid for breast cancer: mechanism of action?, The Lancet Oncology, vol.12, issue.11, pp.991-992, 2011. ,
DOI : 10.1016/S1470-2045(11)70252-2
???? T Cells Predict Outcome in Zoledronate-Treated Breast Cancer Patients, The Oncologist, vol.18, issue.8, pp.22-23, 2013. ,
DOI : 10.1634/theoncologist.2013-0097
URL : http://theoncologist.alphamedpress.org/content/18/8/e22.full.pdf
An unconventional TRAIL to cancer therapy, European Journal of Immunology, vol.8, issue.12, pp.3159-3162, 2013. ,
DOI : 10.1371/journal.pone.0051805
URL : http://onlinelibrary.wiley.com/doi/10.1002/eji.201344105/pdf
Stereotaxic administrations of allogeneic human V??9V??2 T cells efficiently control the development of human glioblastoma brain tumors, OncoImmunology, vol.28, issue.5, p.1168554, 2016. ,
DOI : 10.18632/oncotarget.1201
Structure Based Refinement of a Humanized Monoclonal Antibody That Targets Tumor Antigen Disialoganglioside GD2, Frontiers in Immunology, vol.25, issue.1, p.372, 2014. ,
DOI : 10.1093/protein/gzr053
URL : http://journal.frontiersin.org/article/10.3389/fimmu.2014.00372/pdf
Human ???? T Lymphocytes Are Licensed for Professional Antigen Presentation by Interaction with Opsonized Target Cells, The Journal of Immunology, vol.188, issue.4, pp.1708-1716, 2012. ,
DOI : 10.4049/jimmunol.1102654
URL : http://www.jimmunol.org/content/jimmunol/188/4/1708.full.pdf
HER2 and Breast Cancer Stem Cells: More than Meets the Eye, Cancer Research, vol.73, issue.12, pp.3489-3493, 2013. ,
DOI : 10.1158/0008-5472.CAN-13-0260
URL : http://cancerres.aacrjournals.org/content/canres/73/12/3489.full.pdf
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses, Nature Medicine, vol.13, issue.12, pp.1402-1410, 2016. ,
DOI : 10.1016/j.immuni.2015.08.006
URL : http://europepmc.org/articles/pmc5209798?pdf=render
Cross-presenting human ???? T cells induce robust CD8+ ???? T cell responses, Proceedings of the National Academy of Sciences, vol.215, issue.1, pp.2307-2312, 2009. ,
DOI : 10.1111/j.1600-065X.2006.00472.x
URL : http://www.pnas.org/content/106/7/2307.full.pdf
Prolonged antigen survival and cytosolic export in cross-presenting human ???? T cells, Proceedings of the National Academy of Sciences, vol.187, issue.10, pp.8730-8735, 2010. ,
DOI : 10.1084/jem.187.10.1583
URL : http://www.pnas.org/content/107/19/8730.full.pdf
Expanded human blood-derived ?? T cells display potent antigen-presentation functions, Front Immunol, vol.5, p.344, 2014. ,
DOI : 10.3389/fimmu.2014.00344
URL : http://journal.frontiersin.org/article/10.3389/fimmu.2014.00344/pdf
Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL, Breast Cancer Research, vol.82, issue.Suppl 1, p.88, 2011. ,
DOI : 10.1002/jnr.20629
Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats, Proceedings of the National Academy of Sciences, vol.23, issue.4, pp.18507-18512, 2008. ,
DOI : 10.1159/000221981